We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04273646
Recruitment Status : Unknown
Verified April 2020 by Yang Jin, Wuhan Union Hospital, China.
Recruitment status was:  Not yet recruiting
First Posted : February 18, 2020
Last Update Posted : April 14, 2020
Wuhan Hamilton Bio-technology Co., Ltd, China.
Information provided by (Responsible Party):
Yang Jin, Wuhan Union Hospital, China

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : February 15, 2022